Thomas Ott

Thomas Ott has a diverse work experience in the field of research and development. Thomas has worked at various companies and held positions such as Director of Research Development at Quidel, where they focus on developing new molecular diagnostic platforms. Prior to this role, they worked as an Associate Director, Manager of Molecular R&D, Senior Scientist, and Scientist at Quidel, where they were involved in the development of various molecular diagnostic products and obtained regulatory approvals for test kits. Before joining Quidel, Thomas worked as a Research Scientist at ACADIA Pharmaceuticals, where they focused on advancing early GPCR hits to drug candidates. Thomas also worked as a Postdoctoral Scientist at Neurocrine Biosciences, where they conducted research on chemokine receptors. Thomas started their career as a Postdoctoral Fellow at the HRSU Medical Research Council, where they worked on a Ph.D. project.

Thomas Ott attended the University of Cape Town from an unknown start date to 2000, where they completed their Doctor of Philosophy degree in Biochemistry and Molecular Biology. Prior to this, they obtained their Matrik and Abitur from the Deutsche Höhere Privatschule Windhoek in Namibia, but specific dates were not provided.